Renpu(Suzhou)Pharmaceuticals Ltd.

  • Company Profile

    Renpu Pharmaceuticals Ltd. is a Sino-British enterprise; headquartered in Biobay, Suzhou Industrial Park. Renpu Pharma was established at 2010 with 15 million RMB registered capital. Renpu Pharma is dedicating to R&D, production and sale of ocean fish product - unsaturated fatty acid Omega - 3 related drugs and nutraceuticals. Now it has become a premium supplier in the industry.


    R&D team in Renpu Pharma is full of passionate and aggressive talents. Four senior members hold PhD degree (three of them are returnees). The consultancy team in Renpu Pharma is led by Professor Chai Zhi Fang, academician, Chinese Academy of Science, and a number of well known scientists from Chinese academic institutions and oversea experts in drug development.

    More+
    Omega-3

    DHA(Docosahexaenoic Acid)and EPA(Eicosapentaenoic Acid)belong to Omega-3 polyunsaturated fatty acids. They are essential long chain unsaturated fatty acids for human beings. While human can’t generate these two acids in our body, we need to obtain them from daily foods or supplements. Deep sea fishes such as tuna, anchovy, sardine etc. contain large quantities of DHA and EPA in their body.


    DHA is vital in maintaining normal physiological functions of our CNS system, and directly related to the etiology of a variety of neurodegenerative diseases(e.g. Alzheimer's disease, major depression, etc.)if their levels are found to be significantly lower. DHA is of very high concentration in our brain cell membrane and retina, therefore if an infant is not getting sufficient supply of it may have the risk of either neurotic or sight development.

    More+
    News center
  • Home
  • About us
  • Omega-3
  • Products
  • Quality system
  • Contact us
  • All rights reserved Copyright ©2021-2024  Renpu(Suzhou)Pharmaceuticals Ltd.   ICP 2024119302